Combination Chemotherapy with Paclitaxel, Estramustine and Carboplatin for Hormone Refractory Prostate Cancer
Author:
Affiliation:
1. From the Department of Urology, Shimane Medical University, Izumo, Japan
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference20 articles.
1. Phase II study of docetaxel, estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: a final report of CALGB 9780. Cancer and Leukemia Group B;Savarese;J Clin Oncol,2001
2. Cytotoxic chemotherapy for advanced hormone-resistant prostate cancer;Yagoda;Cancer,1993
3. Combined antimicrotubule activity of estramustine and taxol in human prostatic carcinoma cell lines;Speicher;Cancer Res,1992
4. Phase II trial of 96-hour paclitaxel plus oral estramustine phosphate in metastatic hormone-refractory prostate cancer;Hudes;J Clin Oncol,1997
5. Carboplatin in advanced hormone refractory prostatic cancer patients;Canobbio;Eur J Cancer,1993
Cited by 59 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Identification of anoikis-related gene signatures and construction of the prognosis model in prostate cancer;Frontiers in Pharmacology;2024-06-18
2. Paclitaxel and docetaxel resistance in prostate cancer: Molecular mechanisms and possible therapeutic strategies;Biomedicine & Pharmacotherapy;2023-04
3. The role of carboplatin in combination with paclitaxel in patients with castration-resistant prostate cancer;Future Oncology;2022-12
4. Salvage Chemotherapy with Cisplatin, Ifosfamide, and Paclitaxel in Aggressive Variant of Metastatic Castration-Resistant Prostate Cancer;International Journal of Molecular Sciences;2022-11-29
5. Recent Developments and Anticancer Therapeutics of Paclitaxel: An Update;Current Pharmaceutical Design;2022-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3